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Re-programming microorganisms to modify their existing functions and/or to bestow bac-
teria with entirely new-to-Nature tasks have largely relied so far on specialized molecular
biology tools. Such endeavors are not only relevant in the burgeoning metabolic engineer-
ing arena but also instrumental to explore the functioning of complex regulatory networks
from a fundamental point of view. À la carte modification of bacterial genomes thus calls
for novel tools to make genetic manipulations easier. We propose the use of a series of
new broad-host-range mini-Tn5 -vectors, termed pBAMDs, for the delivery of gene(s) into
the chromosome of Gram-negative bacteria and for generating saturated mutagenesis
libraries in gene function studies. These delivery vectors endow the user with the possi-
bility of easy cloning and subsequent insertion of functional cargoes with three different
antibiotic-resistance markers (kanamycin, streptomycin, and gentamicin). After validating
the pBAMD vectors in the environmental bacterium Pseudomonas putida KT2440, their use
was also illustrated by inserting the entire poly(3-hydroxybutyrate) (PHB) synthesis path-
way from Cupriavidus necator in the chromosome of a phosphotransacetylase mutant of
Escherichia coli. PHB is a completely biodegradable polyester with a number of industrial
applications that make it attractive as a potential replacement of oil-based plastics.The non-
selective nature of chromosomal insertions of the biosynthetic genes was evidenced by a
large landscape of PHB synthesis levels in independent clones. One clone was selected
and further characterized as a microbial cell factory for PHB accumulation, and it achieved
polymer accumulation levels comparable to those of a plasmid-bearing recombinant.Taken
together, our results demonstrate that the new mini-Tn5 -vectors can be used to confer
interesting phenotypes in Gram-negative bacteria that would be very difficult to engineer
through direct manipulation of the structural genes.
Keywords: metabolic engineering,Pseudomonasputida,Escherichia coli, transposon mini-Tn5, central metabolism,
chromosomal integration, polyhydroxyalkanoates
INTRODUCTION
Over the last few years, a number of Gram-negative bacteria have
become increasingly attractive chassis for a number of synthetic
biology and metabolic engineering purposes. One conspicuous
case involves the environmental bacterium Pseudomonas putida as
a robust host for strong oxidative bioreactions, together with its
GRAS (generally recognized as safe) status and its inherent abil-
ity to grow on a wide range of substrates (Nikel et al., 2014a).
This situation calls for the expansion of the available tools for re-
wiring its extant genetic features to further extend its metabolic
potential – or even introducing new-to-Nature functions.
One frequently used molecular biology resource for analyses
and manipulations of bacterial genomes is the Tn5 transposon.
Historically, a number of plasmid vectors based on both wild-
type and minimized versions of Tn5 (i.e. mini-transposons) had
allowed the user to introduce stable insertions of foreign DNA
into the chromosome of virtually any Gram-negative bacteria (de
Lorenzo et al., 1990, 1998; Herrero et al., 1990; de Lorenzo and
Timmis, 1994; Martínez-García et al., 2011; Martínez-García and
de Lorenzo, 2012; Nikel and de Lorenzo, 2013a). Such Tn5-derived
elements present clear advantages over the use of their plasmid-
based counterparts for the introduction and expression of heterol-
ogous genes into several bacterial species. These features include
(but are not limited to) (i) the maintenance of the corresponding
transgenes without antibiotic selective pressure, (ii) the long-term
stability of the constructs and the re-usability of the functional
parts, and, furthermore, (iii) Tn5 vectors admit cloning and chro-
somosomal delivery of considerably long DNA fragments. Finally,
as the transposase gene (tnpA) is lost following each transposi-
tion event (Berg, 1989; Reznikoff, 2006, 2008), one added value
of mini-Tn5-vectors is the possibility to use them recursively in
the same host, provided that they bear different selection markers.
Moreover, as the TnpA transposase tends to act in cis (Phadnis
et al., 1986), it promotes the insertion of DNA sequences borne
by the plasmid, irrespective of previous insertions in a given tar-
get chromosome. These features allow for the integration of more
than one DNA cargo into the same genome.
In this study, we report a series of synthetic, modular broad-
host-range mini-Tn5-vectors for the delivery of gene(s) into the
chromosome of a diversity of Gram-negative bacteria and to
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construct saturated mutagenesis libraries for gene function stud-
ies. These vectors were termed pBAMDs, and they enable the
possibility of easy cloning and subsequent chromosomal inser-
tion of functional cargoes with three different and interchangeable
antibiotic-resistance markers (kanamycin, streptomycin, and gen-
tamicin). Moreover, the functional parts of the new vectors can
be easily swapped by digestion with the appropriate restriction
enzymes, allowing for the shuffling of each element as needed.
Potential applications of the new tools are illustrated in two dif-
ferent genetic contexts. In one case, a systematic validation of the
Tn5 vectors was carried out in P. putida KT2440, demonstrat-
ing the potential of the new insertional plasmids to be used in a
sequential fashion for constructing (and deconstructing) complex
phenotypes. In a second case, one of the pBAMD plasmids was
used to insert a gene cluster from Cupriavidus necator, encoding
all the biochemical functions needed for the formation of poly(3-
hydroxybutyrate) (PHB), into the chromosome of Escherichia
coli, thereby resulting in a new microbial cell factory tailored for
biopolymer synthesis.
MATERIALS AND METHODS
BACTERIAL STRAINS, PLASMIDS, AND GROWTH CONDITIONS
The bacterial strains and plasmids used in this study are described
in Table 1. Bacteria were routinely grown batchwise in LB medium
(10 g l−1 tryptone, 5 g l−1 yeast extract, and 5 g l−1 NaCl) with
rotary agitation (170 rpm). P. putida was grown at 30°C while
E. coli cells were grown at 37°C. Selection of P. putida transcon-
jugants was performed by spotting the cells onto M9 minimal
medium agar plates (Sambrook et al., 1989) added with 0.2%
(w/v) sodium citrate as the sole carbon source (to counterse-
lect E. coli cells). PHB accumulation was assessed in selected E.
coli transconjugants cultured in M9 minimal medium containing
30 g l−1 glucose as the sole carbon source. Aerobic culture con-
ditions in experiments aimed at polymer synthesis were achieved
essentially as described by Nikel et al. (2010a), by using a 1:10
culture medium-to-flask volume ratio. Antibiotics were added
at the following final concentrations whenever needed: ampi-
cillin, 150µg ml−1 for E. coli or 500µg ml−1 for P. putida, chlo-
ramphenicol, 30µg ml−1; kanamycin, 50µg ml−1, streptomycin,
80µg ml−1; and gentamicin, 10µg ml−1. All solid media also con-
tained 15 g l−1 agar. Growth was estimated spectrophotometrically
by measuring the optical density at 600 nm (OD600) of the cul-
tures (appropriately diluted in 9 g l−1 NaCl whenever needed) in
a Ultrospec 3000 pro UV/Visible spectrophotometer (GE Health-
care Bio-Sciences Corp., Piscataway, NJ, USA). When culturing
E. coli strains that accumulate PHB, for which OD600 readings
are no longer useful to estimate the cell dry weight (CDW), cells
from 15 ml aliquots were washed, concentrated, and the CDW
determined after drying the samples at 80°C to constant weight as
previously indicated by Nikel et al. (2008a,b).
NUCLEIC ACID MANIPULATIONS AND GENERAL CLONING TECHNIQUES
DNA manipulations followed routine laboratory techniques as
described by Sambrook et al. (1989) and Martínez-García and de
Lorenzo (2012). Plasmid DNA was obtained using the QIAprep
Spin™ Miniprep kit (Qiagen, Inc., Valencia, CA, USA). Restriction
enzymes were obtained from New England Biolabs Inc. (Ipswich,
MA, USA), and T4 DNA ligase was purchased from Roche Applied
Science Co. (Indianapolis, IN, USA). Plasmid p-R-SETA111 was
constructed using isothermal assembly essentially as detailed by
Gibson et al. (2009) but using a home-made mixture of enzymes.
Colony PCR was performed using a single colony from a fresh
LB agar plate and transferred directly into the reaction tube.
PCR reactions were purified either with the NucleoSpin™ Gel
and PCR clean-up kit (Macherey-Nagel GmbH & Co. KG, Düren,
Germany) or the ExoSAP-IT™ PCR product clean-up kit (USB,
Affymetrix Ltd., Santa Clara, CA, USA). Oligonucleotides were
purchased from Sigma-Aldrich Co. (St. Louis, MO, USA). The
oligonucleotides used in this work for specific DNA construc-
tions are indicated in Table S1 in the Supplementary Material;
the oligonucleotides used to identify the location of the chromo-
somal insertions are indicated in Table 2 (see also next section).
The three different mini-Tn5 modules were chemically synthe-
sized de novo by GeneCust Europe S.A. (Dudelange, Luxem-
bourg). DNA sequencing was carried out by Secugen SL (Madrid,
Spain).
Three separate DNA segments, carrying the transposon mod-
ule along with the corresponding antibiotic-resistance determi-
nant, were obtained as follows. In the first step, we used pBAM1
(Martínez-García et al., 2011) as the template to amplify the bla
gene using primers Ap-AsiSI-F and Ap-MluI-R (Table S1 in the
Supplementary Material), thereby substituting the SwaI and PshAI
restriction sites by target recognition sites for AsiSI and MluI,
respectively, while maintaining the transcriptional control of bla
through the native P3 promoter (Brosius et al., 1982). The back-
bone of plasmid pSEVA111 (Silva-Rocha et al., 2013) was ampli-
fied with the SEVA111-F and SEVA111-R oligonucleotide pair to
obtain the second DNA fragment. Finally, the tnpA gene from
pBAM1 was obtained using the oligonucleotides tnpA-SanDI-F
and tnpA-AsiSI-R that add the corresponding SanDI and AsiSI
restriction sites to the amplified fragment. These fragments were
joined together by isothermal assembly, giving rise to plasmid
p-R-SETA111 (Figure S1 in Supplementary Material).
Tripartite conjugative matings were set using E. coli CC118
λpir (carrying pBAMD1-x, where x stands for any of the three
antibiotic markers; see below) as the donor strain, the mating-
helper strain E. coli HB101 (carrying pRK600), and P. putida
KT2440 as the recipient strain. Conjugative matings were per-
formed as described elsewhere (Martínez-García et al., 2011;
Martínez-García and de Lorenzo, 2012). Briefly, the OD600 from
overnight cultures grown in LB medium with the appropriate
antibiotics was adjusted to 1, then the cells were washed twice with
10 mM MgSO4 to remove antibiotics from the culture medium,
and each bacterial suspension was added to a 10 ml tube contain-
ing 5 ml of 10 mM MgSO4 to obtain a final OD600 of ca. 0.03.
Biparental matings were done by following a similar procedure,
but using E. coli S17-1 λpir as the donor strain.
The mixture was concentrated by filtration and the cells were
laid onto a filter disk (0.45µm pore-size, 23 mm diameter, EMD
Millipore Corp., Billerica, MA, USA). The filter was placed onto
the surface of an LB agar plate and incubated at 30°C for 6 h.
Finally, the biomass from the filter was suspended in 5 ml of 10 mM
MgSO4 and different dilutions were plated onto a suitable selective
media.
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Table 1 | Bacterial strains and plasmids used in this work.
Bacterial strain or plasmid Relevant characteristicsa Reference or source
Escherichia coli
DH5α λpir Cloning host; F− λ− endA1 glnX44(AS) thiE1 recA1 relA1 spoT1 gyrA96 (NalR)
rfbC1 deoR nupG Φ80(lacZ∆M15 ) ∆(argF -lac)U169 hsdR17 (rK− mK+), λpir
lysogen
Hanahan and Meselson (1983)
CC118 λpir Cloning host; ∆(ara-leu) araD ∆lacX174 galE galK phoA thiE1 rpsE rpoB(RifR)
argE (Am) recA1, λpir lysogen
Herrero et al. (1990)
S17-1 λpir Cloning host; F− recA1 endA1 thiE1 pro-82 creC510 hsdR17 RP4-2(Km:Tn7
Tc:Mu-1), λpir lysogen, SmR
de Lorenzo et al. (1993)
S17P Same as S17-1 λpir but carrying plasmid pBAMD1-6-pha (phaC1AB1+), SmR ApR
GmR
This work
HB101 Helper strain; F− λ− hsdS20(rB− mB−) recA13 leuB6 (Am) araC14 ∆(gpt-proA)62
lacY1 galK2(Oc) xyl-5 mtl-1 thiE1 rpsL20(SmR) glnX44(AS)
Boyer and Roulland-Dussoix (1969)
BW25113 Wild-type strain; F− λ− ∆(araD-araB)567 ∆lacZ4787 (:rrnB-3) rph-1
∆(rhaD-rhaB)568 hsdR514
Datsenko and Wanner (2000)
JW2293-1b Same as BW25113 but ∆pta779:aphA, KmR Baba et al. (2006)
JW2293P Same as JW2293-1 but carrying plasmid pAeT41 (phaC1AB1+), ApR This work
TA2293P Same as JW2293-1 but ykgH :mini-Tn5 (phaC1AB1), expresses the pha gene
cluster from Cupriavidus necator as a chromosomal integration, KmR GmR
This work
Pseudomonas putida
KT2440 Wild-type strain; mt-2 derivative cured of the TOL plasmid pWW0 Bagdasarian et al. (1981)
Plasmids
pRK600 Helper plasmid used for conjugation; ori (ColE1), RK2(mob+ tra+); CmR Kessler et al. (1992)
pBAM1 Mini-Tn5 delivery plasmid; ori (R6K), standard multiple cloning site; ApR KmR Martínez-García et al. (2011)
pSEVA111 Cloning vector; ori (R6K), standard multiple cloning site; ApR Silva-Rocha et al. (2013)
p-R-SETA111 Cloning vector; ori (R6K), standard multiple cloning site, tnpA; ApR This work
pBAMD1-2 Mini-Tn5 delivery plasmid; ori (R6K); ApR KmR This work
pBAMD1-4 Mini-Tn5 delivery plasmid; ori (R6K); ApR SmR/SpR This work
pBAMD1-6 Mini-Tn5 delivery plasmid; ori (R6K); ApR GmR This work
pAeT41 Derivative of cloning vector pUC18 (Thermo Fisher Scientific Inc.; Pittsburgh, PA,
USA) bearing a ca. 5-kb SmaI/EcoRI DNA fragment spanning the phaC1AB1 gene
cluster from C. necator ; ApR
Peoples and Sinskey (1989)
pBAMD1-6-pha Derivative of pBAMD1-6; delivery plasmid used to insert the phaC1AB1 gene
cluster from C. necator into the chromosome of recipient E. coli strains; ApR GmR
This work
aAntibiotic markers: Ap, ampicillin; Cm, chloramphenicol; Gm, gentamicin; Km, kanamycin; Nal, nalidixic acid; Rif, rifampicin; Sm, streptomycin; Sp, spectinomycin;
and Tc, tetracycline.
bStrain obtained from the E. coli Genetic Stock Center (Yale University, New Haven, CT, USA).
LOCALIZATION OF THE mini-Tn5 TRANSPOSON INSERTION SITES BY
ARBITRARY PCR
In order to specifically map the landing sites of the mini-
transposon within the chromosome, a set of oligonucleotides was
designed that specifically hybridizes in each of the mini-Tn5 ele-
ments (Table 2). Transconjugants were streaked onto M9 minimal
medium agar plates with 0.2% (w/v) sodium citrate as the sole
carbon source and supplemented with the appropriate antibiotics
to obtain isolated colonies, which were re-streaked again in the
same culture medium to obtain isolated clones. These colonies
were used as the template for arbitrary PCR. The identification
of the transposon insertion site could be independently obtained
using either the oligonucleotides that are close to the ME-O end
or with the ones designed for the ME-I end. However, when these
plasmids carry any heterologous DNA in the multiple cloning site
(MCS), the use of the oligonucleotides that are close to the ME-
O end is the preferable option, since the ones for the ME-I end
are located downstream the MCS and therefore would amplify
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Table 2 | Oligonucleotides used in this work to identify and sequence the chromosomal locus of mini-Tn5 insertions.
Oligonucleotide Sequence (5′→3′) Use and reference
ARB6 GGCACGCGTCGACTAGTACNNNNNNNNNNACGCC Arbitrary PCR, round 1 (Pratt and Kolter, 1998)
ARB2 GGCACGCGTCGACTAGTAC Arbitrary PCR, round 2 (Pratt and Kolter, 1998)
pBAM-ME-I-Ext-R CTCGTTTCACGCTGAATATGGCTC Arbitrary PCR for pBAMD1-2, round 1 (Martínez-García et al., 2011)
pBAM-ME-I-Int-R CAGTTTTATTGTTCATGATGATATA Arbitrary PCR for pBAMD1-2, round 2, and sequencing
(Martínez-García et al., 2011)
ME-O-Km-Ext-F CGTCTGTTTCAGAAATATGGCAT Arbitrary PCR for pBAMD1-2, round 1
ME-O-Km-Int-F ATCTGATGCTGGATGAATTTTTC Arbitrary PCR for pBAMD1-2, round 2, and sequencing
ME-I-Sm-Ext-R ATGACGCCAACTACCTCTGATA Arbitrary PCR for pBAMD1-4, round 1
ME-I-Sm-Int-R TCACCGCTTCCCTCATGATGTT Arbitrary PCR for pBAMD1-4, round 2, and sequencing
ME-O-Sm-Ext-F CTTGGCCTCGCGCGCAGATCAG Arbitrary PCR for pBAMD1-4, round 1
ME-O-Sm-Int-F CACCAAGGTAGTCGGCAAAT Arbitrary PCR for pBAMD1-4, round 2, and sequencing
ME-O-Gm-Ext-F GCACTTTGATATCGACCCAAGT Arbitrary PCR for pBAMD1-6, round 1
ME-O-Gm-Int-F TCCCGGCCGCGGAGTTGTTCGG Arbitrary PCR for pBAMD1-6, round 2, and sequencing
ME-I-Gm-Ext-R GTTCTGGACCAGTTGCGTGAG Arbitrary PCR for pBAMD1-6, round 1
ME-I-Gm-Int-R GAACCGAACAGGCTTATGTCA Arbitrary PCR for pBAMD1-6, round 2, and sequencing
through it. In the later case, and depending on the length of the
DNA cloned in the MCS, the corresponding amplicon may not
provide long enough a sequence to ascertain the insertion site of
the mini-transposon module.
The conditions of the first round of arbitrary PCR were as fol-
lows: 5 min at 95°C (initial denaturation); six cycles of 30 s at 95°C,
30 s at 30°C, and 90 s at 72°C; and 30 cycles of 30 s at 95°C, 30 s at
45°C, and 90 s at 72°C (Das et al., 2005). The ARB6 oligonucleotide
was used together with the external oligonucleotides within the
mini-transposon (indicated with the “Ext” acronym in Table 2).
Then, we used 1µl of the first PCR round as the template for the
second round of arbitrary PCR by applying the following con-
ditions: 1 min at 95°C (initial denaturation); 30 cycles of 30 s at
95°C, 30 s at 52°C, and 90 s at 72°C; followed by an extra extension
of 4 min at 72°C (Das et al., 2005). For the second round of arbi-
trary PCR, the ARB2 oligonucleotide was used together with the
internal primers within the mini-transposon (indicated with the
“Int” acronym in Table 2). Finally, the PCR amplification product
obtained in the second round was directly purified and sent for
sequencing with the corresponding internal oligonucleotide.
DNA sequences were thoroughly inspected visually for any
error and analyzed using the Pseudomonas Genome Database
(Winsor et al., 2011), and BlastN (Altschul et al., 1990, 1997)
was subsequently employed to map the precise transposon inser-
tion point. To ascertain the conservation level of the 9-bp tar-
get sequence of Tn5 transposase, we resorted to the web-based
application WebLogo 3.4 (Crooks et al., 2004).
ANALYTICAL PROCEDURES
For a coarse estimation of the PHB content in E. coli transcon-
jugants, we resorted to a fluorimetric assay based on Nile red
staining (Spiekermann et al., 1999). Cells were grown overnight in
LB medium with the proper antibiotic. The cultures were diluted
to an OD600 of 0.1 in fresh LB medium containing 30 g l−1 glu-
cose and 200µl aliquots were placed in a 96 well microtiter plate
(Costar™ black plates with clear bottom; Thermo Fisher Scientific
Inc.). After growing the cells for 24 h at 37°C, 0.002 volume of
a Nile red stock solution, freshly prepared by dissolving the dye
(purchased from Sigma-Aldrich Co.) to 1 mg ml−1 in dimethyl
sulfoxide, were added to each well. The microtiter plates were
incubated at 37°C in the dark for 30 min, and the fluorescence
at 585 nm was measured in a SpectraMax M2e plate reader (Mole-
cular Devices, LLC., Sunnyvale, CA, USA) in cells before and after
staining with Nile red. The raw fluorescence readings were nor-
malized to the biomass in each well by dividing the values by the
OD600 of the corresponding culture.
The quantification of PHB content in E. coli via fluorescence-
activated cell sorting (FACS) was conducted by following a slight
modification of the protocol described by Tyo et al. (2006). In
brief, cultures to be analyzed were promptly cooled to 4°C by
placing them in an ice bath for 15 min. Cells were harvested by
centrifugation (5 min, 5,000× g, 4°C), resuspended to an OD600
of 0.4 in cold TES buffer [10 mM Tris·HCl (pH= 7.5), 2.5 mM
EDTA, and 10% (w/v) sucrose], and further incubated on ice for
15 min. Bacteria were recovered by centrifugation as explained
above, and finally resuspended in the same volume of cold 1 mM
MgCl2. A 1 ml aliquot of this suspension was added with 3µl
of an 1 mg ml−1 Nile red solution and incubated in the dark at
4°C for 30 min. Cells were analyzed by FACS immediately after
the staining procedure. FACS was carried out in a MACSQuant™
VYB cytometer (Miltenyi Biotec GmbH, Bergisch Gladbach, Ger-
many). Cells were excited with an Ar laser (488 nm, diode-pumped
solid state), and the Nile red fluorescence at 585 nm was detected
with a 614/50 nm band-pass filter. FACS analysis was done on at
least 50,000 cells and the results were analyzed with the built-in
MACSQuantify™ software 2.5 (Miltenyi Biotec). The geometric
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mean of fluorescence in each sample was correlated to the PHB
content (expressed as a percentage) through a calibration curve as
described previously (Tyo et al., 2006).
Cell-free extracts were obtained from cells harvested by cen-
trifugation from an appropriate culture volume at 4,000× g at
4°C for 10 min and processed as described previously (Nikel and
de Lorenzo, 2013b; Nikel et al., 2014b). The total protein con-
centration in cell extracts was assessed by means of the Bradford
method (Bradford, 1976) using a commercially available kit from
BioRad Laboratories, Inc. (Hercules, CA, USA), with crystalline
bovine serum albumin as the standard for determinations. In vitro
quantification of the specific 3-ketoacyl-coenzyme A (CoA) thio-
lase activity in the thiolysis direction was conducted according to
the protocols developed by Palmer et al. (1991) and Slater et al.
(1998), with some modifications. The assay mixture (1 ml) con-
tained 65 mM Tris–HCl (pH= 7.5), 50 mM MgCl2, 62.5µM CoA,
and 65µM 3-acetoacetyl-CoA (Sigma-Aldrich Co.). Solutions of
both CoA and 3-acetoacetyl-CoA were freshly prepared just prior
to the assay. The assay was initiated upon the prompt addition of
the cell-free extract, and the disappearance of 3-acetoacetyl-CoA
was measured with time at 304 nm (using an extinction coef-
ficient for 3-acetoacetyl-CoA ε304= 16.9× 103 M−1 cm−1). One
enzyme unit was defined as the amount of enzyme catalyzing the
conversion of 1µmol of substrate to product per min at 25°C.
Residual glucose and acetate concentrations in culture super-
natants were determined in selected samples using adequate enzy-
matic kits (R-Biopharm AG, Darmstadt, Germany), essentially as
per the manufacturer’s instructions. In either case, control mock
assays were made by spiking M9 minimal medium with different
amounts of the metabolite under examination. Metabolite yields
and kinetic culture parameters were analytically calculated from
the raw growth data as described elsewhere (Nikel et al., 2008a,
2010a, 2014b; Nikel and de Lorenzo, 2013a,b).
STATISTICAL ANALYSIS
The reported experiments were independently repeated at least
twice (as indicated in the corresponding figure legend), and the
mean value of the corresponding parameter± SD is presented.
When appropriate, data were statistically treated with an unpaired
Student’s t test, and 95% confidence intervals for each parameter
were calculated to demonstrate a statistically significant difference
in means among the experimental samples. For the flow cytome-
try experiments, the geometric mean values (from which the PHB
content is derived) were analyzed via the Mann–Whitney U test.
NUCLEOTIDE SEQUENCE ACCESSION NUMBERS
The sequences of the pBAMD vectors were deposited in the
GenBank database with the following GenBank accession num-
bers: KM403113 (pBAMD1-2), KM403114 (pBAMD1-4), and
KM403115 (pBAMD1-6).
RESULTS AND DISCUSSION
RATIONALE, DESIGN, AND GENERAL CHARACTERISTICS OF THE
mini-Tn5 -BASED VECTORS pBAMDs
Vector pBAM1 (born again mini-transposon) is a synthetic and
modular plasmid with a number of features to facilitate the
genome editing of Gram-negative bacteria (Martínez-García et al.,
2011). We decided to further extend the range of such applica-
tions by constructing a new set of pBAM1-derivative plasmids,
which are compatible with the rules set in the Standard European
Vector Architecture (SEVA) format (Silva-Rocha et al., 2013). We
decided to accomplish this challenge by constructing a standard-
ized version of the mini-transposon delivery plasmid that take
full advantage of all the benefits of the pBAM1 plasmid together
with the functional elements available within the SEVA collec-
tion. The starting idea was to design a plasmid series in which the
mini-transposon module, the antibiotic-resistance marker, and
the tnpA could be easily interchanged at the user’s will. In doing
so, several changes were needed to re-structure the constituents of
pBAM1, giving rise to three plasmids that were collectively termed
pBAMD (i.e., pBAM derivative) vectors. These insertion plasmids
share all the advantages and several structural features of their
pBAM1 predecessor. In brief, these features include (i) the nar-
row host-range origin of replication of plasmid R6K [ori(R6K)],
dependent on the Π protein (encoded by the pir gene of plas-
mid R6K); (ii) an origin of transfer, oriT, that allows for the
conjugative transfer of the plasmid from a host strain to a new
bacterial recipient through RK2-mediated mobilization; (iii) the
bla-encoded β-lactamase marker that confers resistance to ampi-
cillin as a selective marker of the backbone vector; and [iv] a
modified, hyper-active transposase encoded by tnpA just outside
(but adjacent to) a DNA segment that is flanked by the termi-
nal sequences of Tn5 (i.e., the mini-transposon module itself).
The Tn5-transposition system is an optimal source of biological
parts because of its genetic promiscuity, and it can be consid-
ered to operate as a virtually orthogonal part, since it displays
an autonomous behavior with respect to the host metabolic and
regulatory traits.
We first constructed an intermediary plasmid, named p-R-
SETA111, that was later used as the backbone in which the dif-
ferent mini-Tn5 antibiotic modules were implanted to obtain the
pBAMD1-x vectors. A mixture of three separate DNA fragments
were isothermally assembled (Gibson et al., 2009) to construct the
p-R-SETA111 intermediary plasmid (Figure S1 in Supplementary
Material). The sequence of p-R-SETA111 was thoroughly checked
after assembling with the set of oligonucleotides described in Table
S1 in the Supplementary Material. This intermediate vector bears
an R6K origin of replication that depends on the Π protein sup-
plied in trans (Kolter et al., 1978) for replication. This situation
calls for the use of E. coli pir+ strains to propagate these plas-
mids (Miller and Mekalanos, 1988; Herrero et al., 1990), such as
E. coli DH5α λpir, CC118 λpir, or S17-1 λpir (Table 1). Another
feature of plasmid p-R-SETA111 is the presence of a minimized
origin of transfer (oriT ) from the promiscuous conjugative plas-
mid RP4 (Lyras and Rood, 1998; Silva-Rocha et al., 2013). Another
trait of this intermediary vector shared with the SEVA plasmids is
that the cargo module is flanked by the strong T1 and T0 tran-
scriptional terminators (Silva-Rocha et al., 2013), which isolate
transcriptionally any DNA sequence cloned in the MCS of p-R-
SETA111. Importantly, the modular design of this plasmid allows
for the convenient exchange of the tnpA by restriction of p-R-
SETA111 with the rare cutters SanDI (5′-GG/GWCCC-3′, W=A
or T; Simcox et al., 1995) and AsiSI (5′-GCGAT/CGC-3′). Like-
wise, the antibiotic marker of the plasmid backbone (bla in this
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particular case), can be easily exchanged by enzymatic restriction
with AsiSI and MluI (5′-A/CGCGT-3′).
Three different mini-Tn5 modules were designed as the cargo
segments to be implanted into the p-R-SETA111 plasmid. These
elements were devised as cargoes for the SEVA plasmid collection
(Silva-Rocha et al., 2013; Durante-Rodríguez et al., 2014), and so
they were bracketed by PacI and SpeI restriction sites. The cargo
modules have a similar structural design, only differing in the
antibiotic marker placed within the mini-transposon (see below).
The mini-Tn5 modules are flanked by the two mosaic end (ME)
sequences. ME elements are optimized 19-bp DNA sequences rec-
ognized by the Tn5 TnpA transposase to promote the specific
transposition of any DNA segment bracketed by these elements
(Zhou et al., 1998). Even though they are identical in sequence,
and with the aim to facilitate the orientation of each functional
element within the plasmid, we termed them as either ME-I (the
one just after the PacI recognition site) or ME-O (the one close to
the SpeI recognition site).
The next relevant feature, placed right after the ME-I element,
is a 10-bp buffer DNA sequence that is immediately followed by
a MCS (spanning recognition sites for AvrII, SfiI, Not I, EcoRI,
SacI, SmaI, BamHI, XbaI, SalI, Pst I, SphI, HindIII, and Not I, in
the 5′→ 3′ direction). This DNA stretch has the same restriction
sites as those present in cargo 1 in the SEVA database. The syn-
thetic T500 terminator (Yarnell and Roberts, 1999) was placed
after the MCS in order to avoid any transcriptional read-through
that any heterologous DNA cloned within the cargo can leak into
the following component of the plasmid. The next functional
element of the mini-transposon is the antibiotic selection marker
that allows for the proper selection of transconjugants. For this
set of plasmids, we have used resistances to kanamycin (aphA,
encoding an aminoglycoside 3′-phosphotransferase; Martínez-
García et al., 2011), streptomycin/spectinomycin (aadA, encod-
ing a streptomycin 3′′(9)-O-nucleotidyl transferase; Fling et al.,
1985), and gentamicin (aacC1, encoding a gentamicin 3′-N -
acetyltransferase; Kovach et al., 1995). These antibiotic-resistance
cassettes are coded as 2, 4, and 6 in the SEVA database. Since
the antibiotic selection cassettes are flanked by SwaI and PshAI
recognition sites, the user has the ability to further expand the
plasmid collection by exchanging the cognate resistance genes
with any of the two other markers present in the SEVA collec-
tion, i.e., cat (encoding a chloramphenicol O-acetyltransferase) or
tetA (encoding a tetracycline efflux protein). The rho-independent
transcriptional terminator from the gene 32 encoded in the phage
T4 genome (Gorski et al., 1985; Miller et al., 2003; Martínez-
García et al., 2011) was placed immediately downstream to the
antibiotic-resistance gene to prevent any possible read-through
from the corresponding promoter elements. Furthermore, the
motif 5′-GGGACCC-3′ was changed to 5′-CGGACCC-3′ to elim-
inate a SanDI restriction target within the existing terminator
sequence.
The last step in the construction of the pBAMD1-x vectors
was the insertion of the mini-transposon modules themselves into
the p-R-SETA111 backbone. The sequences of the three mini-Tn5
modules were edited in silico to follow the SEVA rules and syn-
thesized de novo. The mini-transposon modules were restricted
FIGURE 1 | Functional features of the pBAMD1-x delivery vectors.
(A) Schematic representation of the pBAMD1-x plasmid series. The
functional elements of each plasmid include the relevant restriction
sites used for assembling the vectors, the antibiotic-resistance markers
(Ap, ampicillin; Km, kanamycin; Sm, streptomycin; Sp, spectinomycin;
and Gm, gentamicin), the hyper-active TnpA transposase encoded by
tnpA, a conditional origin of replication [ori (R6K)] dependent of the pi
protein, an origin of transfer (oriT ), two mosaic elements (termed ME-I
and ME-O), the transcriptional terminators T0 and T1 located just
outside the transposon module, and a multiple cloning site (MCS)
compatible with any plasmid belonging to the Standard European Vector
Architecture (SEVA) initiative (Silva-Rocha et al., 2013;
Durante-Rodríguez et al., 2014). Note that the antibiotic-resistance gene
determines the full name of each plasmid. (B) Restriction enzymes
targets within the multiple cloning site of the pBAMD1-x delivery
vectors (x =2, KmR; x =4, SmR/SpR; and x =6, GmR). The MCS starts
with the unique Avr II/Sfi I recognition sites, and two Not I recognition
sites (highlighted in red) were included in the MCS sequence to enable
the consecutive assembly of different cargos from the SEVA collection.
The sequence of ME-I is indicated by a purple box.
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using PacI and SpeI and inserted into p-R-SETA111 previously
digested with the same enzymes. The correctness of this last
cloning step was verified by DNA sequencing with the SEVA
oligonucleotides PS1 and PS2 (Table S1 in the Supplementary
Material), that flank the cargo module. The resulting delivery plas-
mids were termed pBAMD1-2 (KmR), pBAMD1-4 (SmR/SpR),
and pBAMD1-6 (GmR) (Figure 1A). Note that the first digit
numeric nomenclature stems for the fact that all the pBAMD1-
x vectors are derivatives of the pSEVA111 vector, while the second
number identify the antibiotic-resistance marker. All the vectors
share the same MCS (Figure 1B), also compatible with the rest of
SEVA vectors already available.
FUNCTIONAL VALIDATION OF THE pBAMD1-x VECTORS IN P. PUTIDA
KT2440
To evaluate the functionality of the new set of Tn5 plasmids, the
frequency of transposition into the environmental bacterium P.
putida KT2440 was firstly tested in 6 h triparental mating assays.
In order to estimate the frequency of transposition events, the
number of antibiotic-resistant colonies was assessed after 24 h
of incubation at 30°C, and normalized to the total of 1.5× 108
recipient cells used in each experiment. The average frequency of
transposition obtained at 6 h was (3.8± 2.9)× 10−4 transconju-
gants (ranging from a minimum of 2.5× 10−5 to a maximum of
1.0× 10−3 transconjugant cells). These figures were independent
of the antibiotic marker used (either pBAMD1-2, pBAMD1-4, or
pBAMD1-6), and no spontaneous antibiotic-resistant clones (i.e.,
KmR, SmR, or GmR, respectively) were detected under such growth
conditions (data not shown).
The next step was to differentiate between bona fide transposi-
tion events and non-specific plasmid integration events in the P.
putida genome. To do so, transconjugants cells were re-streaked
onto LB medium plates containing 500µg ml−1 ampicillin and
incubated for 24 h to check for possible growth – which would
indicate that the corresponding pBAMD vector had integrated into
the target chromosome instead of transposing the MEs-flanked
DNA cargo. Besides this simple test, the user could also perform
colony PCR amplifications to confirm that the transconjugants
do not have the pBAMD plasmid backbone by using any of the
following two SEVA oligonucleotides combination. If the plas-
mid is present, the PS5-PS4 oligonucleotide pair will produce a
225-bp amplicon within the oriT region, and the PS5-PS6 oligonu-
cleotide pair will generate a 665-bp amplicon including the oriT
segment and the R6K origin of replication (Silva-Rocha et al.,
2013). By conducting these two assays, we noticed that 4.2± 2.4%
of the potential transconjugants obtained with the pBAMD vec-
tors resulted from plasmid co-integration events (a percentage very
similar to that reported for other Tn5-based plasmid systems; de
Lorenzo et al., 1990). Therefore, it is highly recommended to con-
firm the nature of the antibiotic-resistant clones obtained after
each round of insertions.
We also studied whether the pBAMD mini-transposon delivery
plasmids can be used serially to generate double and even triple
transconjugant mutants by taking advantage of the three different
antibiotic resistance markers (Figure 2A). A first round of transpo-
sition was performed with the three individual pBAMD plasmids
using P. putida KT2440 as the recipient strain. Transconjugants
FIGURE 2 | Functional characterization of the pBAMD1-x delivery
vectors in P. putida KT2440. (A) Sequential insertion of different mini-Tn5
modules from pBAMD1-x plasmids carrying all the three possible
antibiotic-resistance determinants. The flowchart shows the procedure
followed for the combinatorial integrations, starting from the wild-type
strain KT2440. The names given to the intermediate strains reflect the order
in which each antibiotic was delivered into the recipient bacteria (K,
kanamycin; S, streptomycin/spectinomycin; and G, gentamicin). The exact
chromosomal localization of the insertions in these strains is given in
Table 3. Plasmids used in each round of integration are indicated in red. (B)
Assessment of the possible sequence preference in the target DNA during
the insertion process of the pBAMD1-x delivery vectors in P. putida
KT2440. The WebLogo 3.4 software was used to identify the DNA signature
(if any) in which the transposon lands in the chromosome of recipient
bacteria. The software was fed with the 9-bp DNA sequence targeted by
mini-Tn5 in independent trials (Table 3). Note the slight preference for G/C
pairs at both ends of the target DNA motif (i.e., in positions 1 and 9).
were re-streaked onto M9 minimal medium plates contain-
ing 0.2% (w/v) citrate and supplemented with the appropriate
antibiotics to obtain isolated colonies. These colonies were re-
streaked again in the same culture medium to obtain pure clones.
We randomly picked 22 clones obtained with each pBAMD1-x
plasmid and characterized the corresponding transposon inser-
tion site. In 12 out of 22 transconjugant clones, the ME-O related
oligonucleotides (Table 2) were used, while in the remaining 10
transconjugant clones, the sequence was obtained by using the
ME-I related oligonucleotides for the arbitrary PCR amplifica-
tion. One KmR clone after the first round of transposition with
pBAMD1-2 was selected and used as the recipient strain for the
pBAMD1-4 and pBAMD1-6 mini-transposon plasmids. After this
second insertion round, we selected four transconjugants obtained
with each system, and mapped the landing point of the mini-
transposon using only the ME-O related oligonucleotides. Finally,
we selected one P. putida KT2440 KmR and GmR and one P. putida
KT2440 KmR and SmR to perform the third round of transposition
with either pBAMD1-4 or pBAMD1-6, respectively. In the last step,
we have chosen one mutant per plasmid system and characterized
again the insertion site of the three mini-transposons using the
ME-O oligonucleotides. The precise site of transposon insertion
could be ascertained in 30 transconjugants out of 32 independent
clones (Table 3). Specifically, in one of the cases in which it was
not possible to identify the localization of the mini-Tn5 element,
the transposon insertion could have happened in either PP2612
or PP3616, since both genes share a 97% sequence identity. In the
other case, the transposon insertion site could not be precisely
mapped due to the presence of a large number of internal repeats
within the lapA gene (PP0168).
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Table 3 | Insertion sites of the mini-transposon born by the different pBAMD1-x vectors in the genome of P. putida KT2440a.
Clone End Genome coordinate (bp) PP number Strand Gene name and putative function
KT-K1 ME-I 5,825,403 PP5103 − trmB, tRNA (guanine-N7-) methyltransferase
KT-K2 ME-I 425,161 PP0349 − PepSY-associated transmembrane helix
domain-containing protein
KT-K3 ME-I 5,272,887 PP4648 + rRNA (guanine-N2-) methyltransferase
KT-K5 ME-O 864,889 PP0745 − uraA, uracil-xanthine permease
KT-K6 ME-O 4,661,528 PP4124 + nuoG, NADH dehydrogenase subunit G
KT-K7 ME-O 1,261,995 PP1104 − Succinyl-glutamate desuccinylase/aspartoacylase
KT-K8 ME-O 727,311 PP0621 − Hypothetical protein
KT-G1b ME-O 2,988,216 PP2612 − Hypothetical protein
4,108,354 PP3616 + Hypothetical protein
KT-G2 ME-O 1,313,801 PP1145 − hepA, ATP-dependent helicase
KT-G3 ME-O 3,002,652 PP2626 + Hypothetical protein
KT-G4 ME-O 3,251,143 PP2847 + ureJ, hydrogenase/urease accessory protein
KT-G6 ME-I 4,444,716 PP3941 − Isochorismatase superfamily hydrolase
KT-G7 ME-I 4,792,981 PP4221 − Non-ribosomal peptide synthetase
KT-G8 ME-I 1,959,862 PP1757 + bolA, BolA family protein
KT-S1 ME-I 4,463,594 PP3956 + Hypothetical protein
KT-S2 ME-I 3,552,337 PP3136 NA Intergenic region (PP3136 and PP3137)
KT-S3 ME-I 4,671,241 PP4132 − Hypothetical protein
KT-S4 ME-I 35,484 PP0031 − Hypothetical protein
KT-S5 ME-O 2,422,455 PP2123 + moeA, molybdopterin biosynthesis enzyme
KT-S6 ME-O 6,021,399 PP5272 − Hypothetical protein
KT-S7 ME-O 381,423 PP0317 − Methyl-accepting chemotaxis sensory transducer
KT-S8 ME-O 328,477 PP0270 − Integral membrane sensor signal transduction
histidine kinase
KT-K2-G1 ME-O 4,892,623 PP4301 + pykF, pyruvate kinase
KT-K2-G2 ME-O 3,749,626 PP3313 − Heat shock protein
KT-K2-G3 ME-O 5,842,545 PP5120 + Conifer aldehyde dehydrogenase
KT-K2-G4 ME-O 1,373,720 PP1199 − Hypothetical protein
KT-K2-S1 ME-O 2,904,080 PP2556 − Chromate transporter
KT-K2-S2 ME-O 5,347,381 PP4703 + Hypothetical protein
KT-K2-S3 ME-O 1,542,387 PP1353 + Mechanosensitive ion channel protein MscS
KT-K2-S4 ME-O 5,892,275 PP5166 − Fis family transcriptional regulator
KT-K2-G1-S1 ME-O 3,635,742 PP3202 + Predicted exporter of the RND superfamily
KT-K2-S4-G1b ME-O NA PP0168 + lapA, surface adhesion protein
aThe insertion sites were ascertained by means of arbitrary PCR with the oligonucleotides indicated inTable 2, and the assigned function of the corresponding ORF
is given according to the information available in the Pseudomonas Genome Database (Winsor et al., 2011). NA, not available.
bIn the two transconjugant clones indicated, the insertion site of the mini-Tn5 element could not be unambiguously identified.
We then used the insertion sequence data of each mapped
clone in Table 3 to detect any sequence preference for the inte-
gration of the mini-Tn5 cassettes within the genome of P. putida
KT2440. The web-based application WebLogo 3.4 (Crooks et al.,
2004) was fed with the 9-bp landing sequence targeted by the mini-
transposon. The program was set to show the probability of having
a defined base at any specific position within the 9-bp motif, and
the G+C percentage of the genome was adjusted to the value of P.
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FIGURE 3 | Construction of an E. coli cell factory expressing the
phaC1AB1 gene cluster from C. necator as a chromosomal insertion. (A)
Poly(3-hydroxybutyrate) (PHB) biosynthesis pathway. Three enzymes are
necessary for de novo synthesis of PHB in C. necator : a 3-ketoacyl-coenzyme
A (CoA) thiolase (PhaA), a NADPH-dependent 3-acetoacetyl-CoA reductase
(PhaB1), and a PHB synthase (PhaC1). PhaA and PhaB1 catalyze the
condensation of two molecules of acetyl-CoA to 3-acetoacetyl-CoA and the
reduction of acetoacetyl-CoA to R-(–)-3-hydroxybutyryl-CoA, respectively.
PhaC1 polymerizes these monomers to PHB, whereas one CoA-SH molecule
per monomer is released. The resulting PHB polymer is stored as
water-insoluble granules in the cytoplasm of the cells. (B) Organization of the
functional elements borne by plasmid pBAM1-6-pha and transferred into the
chromosome of the recipient E. coli strain. The transcriptional terminators
included in the plasmid backbone, which flank the gentamicin resistance
(GmR) determinant (accC1), are depicted as T500 and T32. Note that the
elements in this outline are not drawn to scale. (C) Exploring the landscape of
PHB synthesis in E. coli transconjugants. The phaC1AB1 gene cluster from C.
necator was randomly integrated into the chromosome of E. coli JW2293-1
(∆pta), and 24-h cultures of individual colonies were analyzed for PHB
accumulation by fluorimetry after staining the cells with Nile red (see
Materials and Methods for details). Several colonies, identified by numbers in
the heat-map, were kept and further analyzed to establish the precise site of
mini-Tn5 (phaC1AB1) insertion (Table S2 in the Supplementary Material). AFU,
arbitrary fluorescence units.
putida KT2440 (G+C= 61.5%; Nelson et al., 2002). The results
shown in Figure 2B reveal that there is no DNA sequence bias for
the integration site of the mini-transposon, in a similar fashion
as observed for plasmid pBAM1 (Martínez-García et al., 2011).
However, a relatively minor preference for G/C pairs at both ends
of the target DNA motif could be observed, as detected for other
systems based on Tn5 (Lodge et al., 1988). These experiments
confirm that the three mini-transposons borne by the pBAMD1-
x vectors could be used serially to generate a second or even a
third round of insertion mutagenesis procedure, or also to sta-
bly integrate multiple genetic devices into the genome of a single
microbial strain.
DESIGN AND CONSTRUCTION OF A MICROBIAL CELL FACTORY FOR
POLY(3-HYDROXYBUTYRATE) SYNTHESIS
Engineering an stable PHB+ phenotype in E. coli
Poly(3-hydroxybutyrate) is an isotactic polyester composed by 3-
hydroxybutyrate units (Anderson and Dawes, 1990). The PHB
synthesis pathway in C. necator (formerly known as Ralstonia
eutropha) comprises three enzymes (Figure 3A) (Steinbüchel and
Hein, 2001). PhaA, a 3-ketoacyl-CoA thiolase, condenses two
acetyl-CoA moities,yielding 3-acetoacetyl-CoA. This intermediate
is the substrate for PhaB, a NADPH-dependent 3-acetoacetyl-CoA
reductase (encoded by phaB1). In the final step of this biosyn-
thetic pathway, (R)-(–)-3-hydroxybutyryl-CoA is polymerized to
PHB by PhaC, a poly(3-hydroxyalkanoate) synthase (encoded by
phaC1). The very idea of a thermoplastic and biocompatible mate-
rial, which is also readily biodegraded by a number of bacteria
has become very attractive in an era of increasing environmental
concern (Keshavarz and Roy, 2010). A number of different recom-
binant E. coli strains designed for polymer accumulation have been
constructed thus far (Li et al., 2007; Chen et al., 2013; Ruiz et al.,
2013), outsourcing the pha genes from several bacteria (Verlin-
den et al., 2007). However, most of the PHB production systems
available thus far suffer from a number of drawbacks (Wang et al.,
2014). Among them, the transcriptional regulation of the pha
genes is of particular importance. In natural producer bacteria,
PHB accumulation is triggered by an imbalance in the availability
of critical nutrients (e.g., the N or S source; Anderson and Dawes,
1990). In recombinant E. coli, however, the constitutive expression
of the pha genes leads to a growth-dependent accumulation of
PHB, which normally results in metabolic burden in the producing
cells (Wang and Lee, 1997). Controlling the rate of polymer accu-
mulation in recombinant E. coli is thus of paramount importance
for the design of efficient microbial cell factories. Besides this fea-
ture, the segregational stability of plasmids in E. coli recombinants
could also be an issue in prolonged fermentation processes aimed
at biopolymer production (Nikel et al., 2010b; Ruiz et al., 2013).
To overcome this state of affairs, we decided to explore the
landscape of potentially useful transcription levels in E. coli by
randomly integrating the pha genes from C. necator into the chro-
mosome. To this end, we used vector pBAMD1-6 as the backbone
to clone a 5.3-kb DNA fragment spanning the phaC1AB1 genes.
Plasmid pAeT41 (Peoples and Sinskey, 1989) was digested with
EcoRI and SmaI to liberate the aforementioned DNA segment,
and inserted into the corresponding restriction sites of pBAMD1-
6 to generate plasmid pBAMD1-6-pha (Table 1). The functional
parts of the DNA element to be transferred into E. coli are shown
in Figure 3B.
As acetyl-CoA is the precursor metabolite for PHB formation,
competing pathways that use this intermediate are expected to
drain building blocks of the biopolymer synthesis. In E. coli, the
acetate formation pathway, comprising Pta and AckA (phospho-
transacetylase and acetate kinase), uses acetyl-CoA as the starting
metabolite (Neidhardt et al., 1990). This pathway, which diverts
a considerable amount of carbon from the central metabolism
(Wolfe, 2005), is active under both oxic and anoxic conditions
(Clark, 1989). For this reason, the phaBAC gene cluster was
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delivered into a∆pta recipient strain (Table 1), in which the acetate
formation is expected to be low. Plasmid pBAMD1-6-pha was first
transferred to E. coli S17-1 λpir to perform a biparental mating.
E. coli S17-1 λpir or SM10 λpir are the preferred donor strains
when mobilizing RP4-based plasmid to E. coli recipient strains
since they bear the functional tra and mob elements integrated in
the genome, thus avoiding the inadvertent transfer of the mating-
helper plasmid (pRK600) alongside the mini-transposon delivery
system. Alternatively, E. coli strain MFD pir+ (Ferrières et al.,
2010), devoid of the Mu element present in the strains detailed
above, could be used for transposon insertions.
After integration of the mini-Tn5:phaC1AB1 device into E. coli
JW2293-1, individual GmR colonies were purified and separately
grown in microtiter plates as explained in the Section “Materials
and Methods” to explore PHB accumulation in 100 indepen-
dent transconjugants after 24 h of incubation. Figure 3C shows
the level of PHB accumulation in the transconjugants as com-
pared to that of E. coli JW2293-1 carrying the pAeT41 plasmid,
in which the expression of the phaC1AB1 gene cluster is driven
by the native promoter. All the transconjugants tested accumu-
lated the polymer from mono-copy chromosomal insertions of
the PHB biosynthesis pathway to some extent, ranging from 3%
up to 78% of the accumulation levels observed in E. coli JW2293P
(which carries plasmid pAeT41). Table S2 in the Supplementary
Material shows the insertion locus for some selected phaC1AB1+
transconjugants, clearly illustrating the non-selective nature of the
chromosomal incorporation of Tn5 (and consequently, the wide
range of PHB accumulation levels), as it was already observed in
P. putida transconjugants. We selected one of the transconjugants,
termed E. coli TA2293P, that accumulated high polymer levels
(clone 1 in Figure 3C and Table S2 in Supplementary Material),
and the insertion site of the transposon was determined to be ykgH,
an open reading frame encoding a predicted inner membrane pro-
tein (Table S2 in the Supplementary Material). The physiology of
PHB accumulation of this strain was studied as detailed below.
Physiological and biochemical characterization of E. coli TA2293P
as a microbial cell factory for PHB synthesis
The growth parameters of several E. coli strains were determined
to explore their potential as biopolymer cell factories (Table 4).
We decided to compare the performance of strains in which the
pha genes are expressed either in a multi-copy plasmid or as a
mono-copy insertion in the bacterial chromosome side-by-side.
Interestingly, the elimination of Pta resulted in a reduction of the
specific growth rate, probably by an imbalance in the acetyl-CoA
pool that was partially restored by the heterologous expression of
the phaC1AB1 gene cluster. This positive effect was more evident
in the strain in which the genes were inserted into the chromosome
(the specific growth rate attained ca. 85% of that in the wild-type
strain), thus suggesting that the adequate expression level of the
PHB biosynthesis genes is important to recover a homeostatic
acetyl-CoA balance. This kinetic pattern was also mirrored in the
final biomass density of the cultures. In fact, among the strains
tested, E. coli TA2293P attained the highest cell density. This result
highlights the advantage of integrating the pha genes in the chro-
mosome, as such approach not only avoids the metabolic burden
usually associated with heterologous gene expression from plas-
mids and other extra-chromosomal elements but it also allows
for the selection of an integrant strain exhibiting the appropriate
level of transcription of the corresponding genes. Moreover, the
selection of ykgH as a target was not at all obvious, indicating,
again, the value of random insertion of the genes of interest in the
bacterial chromosome.
Since we selected a pta mutant of E. coli as the recipient strain,
in which acetate formation is expected to be impaired, by-product
formation was also explored in these cultures as a measure of the
carbon flow from glucose to PHB (Table 4). In cultures of the wild-
type strain, up to 60% of the total carbon source was converted into
acetate, pinpointing this metabolite as the key by-product of hex-
ose catabolism in E. coli (and therefore, as the main side pathway
competing for acetyl-CoA). The pta mutant still produced some
acetate (probably through the action of pyruvate oxidase, PoxB);
however, the molar conversion of glucose into acetate reached only
ca. 20% of that observed in the wild-type strain. Acetate forma-
tion in both E. coli strains carrying PhaC1AB1 was comparable,
and much lower than the other two strains. In all, these results bear
witness of (i) the suitability of a pta mutant, deficient in acetate for-
mation, as the starting point to construct a PHB cell factory, and
(ii) the effect of the PHB biosynthetic pathway in using acetyl-
CoA as the precursor metabolite. Once the coarse physiological
Table 4 | Physiological characterization of wild-type and mutant E. coli strains as microbial cell factories for PHB biosynthesis in shaken-flask
cultures.
E. coli strain Relevant characteristics Physiological parametera
µ (h−1) CDW (g l−1) YA/S (mol mol−1)
BW25113 Wild-type strain 0.74±0.04 3.8±0.2 0.64±0.05
JW2293-1 ∆pta 0.44±0.03 2.9±0.3 0.13±0.02
JW2293P ∆pta phaC1AB1+ 0.51±0.07 3.5±0.1 0.05±0.02
TA2293P ∆pta ykgH :mini-Tn5 (phaC1AB1) 0.63±0.05 4.2±0.4 0.09±0.03
aCells were grown aerobically in M9 minimal medium containing 30 g l−1 glucose as the sole carbon source.The specific growth rate (microns) was determined during
logarithmic growth, whereas the final cell density (expressed as the cell dry weight, CDW) and the molar yield of acetate on glucose (YA/S) were calculated after 24 h
of incubation. Reported results represent the mean value±SD of triplicate measurements from at least two independent cultures.
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characterization of these strains was completed, the next relevant
question was how they perform as PHB producers.
Since PhaA is the first committed enzymatic step of PHB for-
mation from acetyl-CoA, the in vitro activity of this enzyme was
assayed as a proxy of the activity of the whole biosynthetic pathway
in shaken-flask cultures using glucose as the sole carbon source
(Figure 4A). Note that there was some degree of thiolase activ-
ity in both E. coli BW25113 and JW2293-1, probably represented
by FadA (an enzyme normally involved in the degradation of
fatty acids via the β-oxidation cycle). However, the specific PhaA
activity was six and fourfold higher in the strains carrying the
phaC1AB1 gene cluster (E. coli JW2293P and TA2293P, respec-
tively) as compared to that of E. coli JW2293-1. As expected, the
highest enzymatic activity corresponded to the strain carrying the
pha genes in a multi-copy plasmid. Nevertheless, E. coli TA2293P
had an activity level ca. 60% of the strain bearing pAeT41, indi-
cating that the appropriate insertion of the gene cluster could
result in thiolase activities similar to those of a typical recombi-
nant PHB producer. Yet, how do these activities translate into PHB
accumulation?
Figure 4B shows that E. coli TA2293P accumulated PHB up
to 62% of the level observed in the same strain but expressing
the pha genes in a plasmid (i.e., E. coli JW2293P). As previously
observed in other traits during the physiological characterization,
the later strain had the highest PHB accumulation level among
all the strains tested. That E. coli TA2293P accumulates such a
high amount of PHB is a somewhat surprising (and welcome)
result considering the difference in copy number between the
two phaC1AB1+ strains under comparison. Note that a possi-
ble effect of the absence (or an altered expression level) of YkgH
on the properties of E. coli TA2293P cannot be completely ruled
out. Interestingly, when this strain was persistently cultured in LB
medium without any selective pressure, its phenotypic traits, par-
ticularly regarding polymer accumulation, remained unchanged.
By contrast, the segregational stability of pAeT41 was assessed in
cultures of E. coli JW2293P, and, after growing the cells in LB
medium and sub-culturing them daily seven times without any
antibiotic,<25% of the cells were resistant to ampicillin.
CONCLUSION
In our current study, we presented a set of new mini-Tn5-derived
vectors that can be used to engineer the genome of Gram-negative
bacteria. While the worth of these tools has been exposed in two
model bacteria, P. putida and E. coli, the inherent promiscuity of
Tn5 ensures its functioning in a number of different microbial
hosts. Of particular importance is the possibility of sequentially
using the three pBAMD1-x vectors, thereby enabling the user to
accumulate insertions in the same genetic background in a com-
binatorial fashion. This is a particularly interesting feature for
the construction of complex phenotypes, such as biopolymer for-
mation, which depend on more than one enzyme. Although the
expression of the biosynthetic genes in a multi-copy plasmid is in
principle enough to bestow the desired phenotype on the recipient
bacterium, fine-tuned expression levels (together with the appear-
ance of emergent phenotypic properties in the host, brought about
by the insertion process itself) can be easily achieved by randomly
FIGURE 4 | Biochemical characterization of E. coli TA2293P as a
microbial cell factory for PHB synthesis. (A) In vitro determination of the
specific (Sp) 3-ketoacyl-coenzyme A thiolase (PhaA) activity. Cells were
harvested after growing them for 24 h in M9 minimal medium added with
30 g l−1 glucose as the sole carbon source, and the activity of PhaA was
determined in the cell-free extract as detailed in the Section “Materials and
Methods.” (B) Poly(3-hydroxybutyrate) (PHB) accumulation. The PHB
content (expressed as a percentage of the cell dry weight) was assessed
by flow cytometry after growing the cells for 24 h in M9 minimal medium
added with 30 g l−1 glucose as the sole carbon source. In all cases, each bar
represents the mean value of the corresponding enzymatic activity±SD of
triplicate measurements from at least two independent experiments. The
strains used to explore these biochemical traits were E. coli BW25113
(wild-type strain), E. coli JW2293-1 (∆pta), E. coli JW2293P (∆pta, carrying
the phaC1AB1 gene cluster in a multi-copy plasmid), and E. coli TA2293P
[∆pta, ykgH :mini-Tn5 (phaC1AB1)]. SeeTable 1 for further details about the
genotype of each E. coli strain. The relevant features of each strain are
indicated at the bottom of the figure.
integrating the structural genes into the chromosome. In this way,
and since the genetic context of each integration will surely result
in different regulatory patterns at the transcriptional level, the user
could choose among a library of insertions those clones that meet
any desired criterion (in our case, PHB accumulation). Moreover,
as the delivery plasmids described in this study can be used in
a sequential manner, other polymer-associated enzymes, such as
phasins, can also be incorporated in the same strain to enhance
further polymer production.
ACKNOWLEDGMENTS
We are indebted to Prof. A. Sinskey (Massachusetts Institute of
Technology) for sharing research materials and to A. Goñi (CNB-
CSIC) for his help in image processing. I. Benedetti (CNB-CSIC)
www.frontiersin.org October 2014 | Volume 2 | Article 46 | 11
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Martínez-García et al. Tools for metabolic engineering of cell factories
is gratefully acknowledged for her help in FACS measurements.
This study was supported by the BIO Program of the Spanish Min-
istry of Economy and Competitiveness, the ST-FLOW and ARISYS
Contracts of the EU, the ERANET-IB Program, and the PROMT
Project of the CAM to VDL. PIN is a researcher from the Consejo
Nacional de Investigaciones Científicas y Técnicas (Argentina) and
holds a Marie Curie Actions Program grant from the EC (ALLE-
GRO, UE-FP7-PEOPLE-2011-IIF-300508). The authors declare
no conflict of interest.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at http://www.frontiersin.org/Journal/10.3389/fbioe.2014.00046/
abstract
REFERENCES
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990). Basic local
alignment search tool. J. Mol. Biol. 215, 403–410. doi:10.1016/S0022-2836(05)
80360-2
Altschul, S. F., Madden, T. L., Schäffer, A. A., Zhang, J., Zhang, Z., Miller, W., et al.
(1997). Gapped BLAST and PSI-BLAST: a new generation of protein database
search programs. Nucleic Acids Res. 25, 3389–3402. doi:10.1093/nar/25.17.3389
Anderson, A. J., and Dawes, E. A. (1990). Occurrence, metabolism, metabolic
role, and industrial uses of bacterial polyhydroxyalkanoates. Microbiol. Rev. 54,
450–472.
Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., et al. (2006). Con-
struction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the
Keio collection. Mol. Syst. Biol. 2, 2006.0008. doi:10.1038/msb4100050
Bagdasarian, M., Lurz, R., Rückert, B., Franklin, F. C., Bagdasarian, M. M., Frey,
J., et al. (1981). Specific-purpose plasmid cloning vectors. II. Broad host range,
high copy number, RSF1010-derived vectors, and a host-vector system for gene
cloning in Pseudomonas. Gene 16, 237–247. doi:10.1016/0378-1119(81)90080-9
Berg, D. E. (1989). “Transposon Tn5,” in Mobile DNA, eds D. E. Berg and M. M.
Howe (Washington, DC: American Society for Microbiology Press), 185–210.
Boyer, H. W., and Roulland-Dussoix, D. (1969). A complementation analysis of the
restriction and modification of DNA in Escherichia coli. J. Mol. Biol. 41, 459–472.
doi:10.1016/0022-2836(69)90288-5
Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of micro-
gram quantities of protein utilizing the principle of protein-dye binding. Anal.
Biochem. 72, 248–254. doi:10.1016/0003-2697(76)90527-3
Brosius, J., Cate, R. L., and Perlmutter, A. P. (1982). Precise location of two promot-
ers for the β-lactamase gene of pBR322. S1 mapping of ribonucleic acid isolated
from Escherichia coli or synthesized in vitro. J. Biol. Chem. 257, 9205–9210.
Chen, X., Zhou, L., Tian, K., Kumar, A., Singh, S., Prior, B. A., et al. (2013). Metabolic
engineering of Escherichia coli: a sustainable industrial platform for bio-based
chemical production. Biotechnol. Adv. 31, 1200–1223. doi:10.1016/j.biotechadv.
2013.02.009
Clark, D. P. (1989). The fermentation pathways of Escherichia coli. FEMS Microbiol.
Rev. 5, 223–234. doi:10.1111/j.1574-6968.1989.tb03398.x
Crooks, G. E., Hon, G., Chandonia, J. M., and Brenner, S. E. (2004). WebLogo: a
sequence logo generator. Genome Res. 14, 1188–1190. doi:10.1101/gr.849004
Das, S., Noe, J. C., Paik, S., and Kitten, T. (2005). An improved arbitrary primed
PCR method for rapid characterization of transposon insertion sites. J. Micro-
biol. Methods 63, 89–94. doi:10.1016/j.mimet.2005.02.011
Datsenko, K. A., and Wanner, B. L. (2000). One-step inactivation of chromosomal
genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U.S.A.
97, 6640–6645. doi:10.1073/pnas.120163297
de Lorenzo, V., Cases, I., Herrero, M., and Timmis, K. N. (1993). Early and late
responses of TOL promoters to pathway inducers: identification of postexpo-
nential promoters in Pseudomonas putida with lacZ -tet bicistronic reporters. J.
Bacteriol. 175, 6902–6907.
de Lorenzo, V., Herrero, M., Jakubzik, U., and Timmis, K. N. (1990). Mini-Tn5
transposon derivatives for insertion mutagenesis, promoter probing, and chro-
mosomal insertion of cloned DNA in Gram-negative Eubacteria. J. Bacteriol.
172, 6568–6572.
de Lorenzo, V., Herrero, M., Sánchez, J. M., and Timmis, K. N. (1998). Mini-
transposons in microbial ecology and environmental biotechnology. FEMS
Microbiol. Ecol. 27, 211–224. doi:10.1111/j.1574-6941.1998.tb00538.x
de Lorenzo,V., and Timmis, K. N. (1994). Analysis and construction of stable pheno-
types in Gram-negative bacteria with Tn5- and Tn10-derived minitransposons.
Meth. Enzymol. 235, 386–405. doi:10.1016/0076-6879(94)35157-0
Durante-Rodríguez, G., de Lorenzo, V., and Martínez-García, E. (2014). The Stan-
dard European Vector Architecture (SEVA) plasmid toolkit. Methods Mol. Biol.
1149, 469–478. doi:10.1007/S978-1-4939-0473-0_36
Ferrières, L., Hémery, G., Nham, T., Guérout, A. M., Mazel, D., Beloin, C., et al.
(2010). Silent mischief: bacteriophage Mu insertions contaminate products of
Escherichia coli random mutagenesis performed using suicidal transposon deliv-
ery plasmids mobilized by broad-host-range RP4 conjugative machinery. J. Bac-
teriol. 192, 6418–6427. doi:10.1128/JB.00621-10
Fling, M. E., Kopf, J., and Richards, C. (1985). Nucleotide sequence of the trans-
poson Tn7 gene encoding an aminoglycoside-modifying enzyme, 3”(9)-O-
nucleotidyltransferase. Nucleic Acids Res. 13, 7095–7106. doi:10.1093/nar/13.19.
7095
Gibson, D. G., Young, L., Chuang, R. Y., Venter, J. C., Hutchison, C. A., and Smith,
H. O. (2009). Enzymatic assembly of DNA molecules up to several hundred
kilobases. Nat. Methods 6, 343–345. doi:10.1038/nmeth.1318
Gorski, K., Roch, J. M., Prentki, P., and Krisch, H. M. (1985). The stability of bac-
teriophage T4 gene 32 mRNA: a 5′ leader sequence that can stabilize mRNA
transcripts. Cell 43, 461–469. doi:10.1016/0092-8674(85)90176-X
Hanahan, D., and Meselson, M. (1983). Plasmid screening at high colony density.
Meth. Enzymol. 100, 333–342. doi:10.1016/0076-6879(83)00066-X
Herrero, M., de Lorenzo, V., and Timmis, K. N. (1990). Transposon vectors con-
taining non-antibiotic resistance selection markers for cloning and stable chro-
mosomal insertion of foreign genes in Gram-negative bacteria. J. Bacteriol. 172,
6557–6567.
Keshavarz, T., and Roy, I. (2010). Polyhydroxyalkanoates: bioplastics with a green
agenda. Curr. Opin. Microbiol. 13, 321–326. doi:10.1016/j.mib.2010.02.006
Kessler, B., de Lorenzo, V., and Timmis, K. N. (1992). A general system to integrate
lacZ fusions into the chromosomes of Gram-negative Eubacteria: regulation of
the Pm promoter of the TOL plasmid studied with all controlling elements in
monocopy. Mol. Gen. Genet. 233, 293–301. doi:10.1007/BF00587591
Kolter, R., Inuzuka, M., and Helinski, D. R. (1978). trans-Complementation-
dependent replication of a low molecular weight origin fragment from plasmid
R6K. Cell 15, 1199–1208. doi:10.1016/0092-8674(78)90046-6
Kovach, M. E., Elzer, P. H., Hill, D. S., Robertson, G. T., Farris, M. A., Roop, R.
M., et al. (1995). Four new derivatives of the broad-host-range cloning vec-
tor pBBR1MCS, carrying different antibiotic-resistance cassettes. Gene 166,
175–176. doi:10.1016/0378-1119(95)00584-1
Li, R., Zhang, H., and Qi, Q. (2007). The production of polyhydroxyalkanoates in
recombinant Escherichia coli. Bioresour. Technol. 98, 2313–2320. doi:10.1016/j.
biortech.2006.09.014
Lodge, J. K., Weston-Hafer, K., and Berg, D. E. (1988). Transposon Tn5 target speci-
ficity: preference for insertion at G/C pairs. Genetics 120, 645–650.
Lyras, D., and Rood, J. I. (1998). Conjugative transfer of RP4-oriT shuttle vec-
tors from Escherichia coli to Clostridium perfringens. Plasmid 39, 160–164.
doi:10.1006/plas.1997.1325
Martínez-García, E., Calles, B., Arévalo-Rodríguez, M., and de Lorenzo, V. (2011).
pBAM1: an all-synthetic genetic tool for analysis and construction of complex
bacterial phenotypes. BMC Microbiol. 11:38. doi:10.1186/1471-2180-11-38
Martínez-García, E., and de Lorenzo, V. (2012). Transposon-based and plasmid-
based genetic tools for editing genomes of Gram-negative bacteria. Methods Mol.
Biol. 813, 267–283. doi:10.1007/978-1-61779-412-4_16
Miller, E. S., Kutter, E., Mosig, G., Arisaka, F., Kunisawa, T., and Rüger, W. (2003).
Bacteriophage T4 genome. Microbiol. Mol. Biol. Rev. 67, 86–156. doi:10.1128/
MMBR.67.1.86-156.2003
Miller, V. L., and Mekalanos, J. J. (1988). A novel suicide vector and its use in con-
struction of insertion mutations: osmoregulation of outer membrane proteins
and virulence determinants in Vibrio cholerae requires toxR. J. Bacteriol. 170,
2575–2583.
Neidhardt, F. C., Ingraham, J. L., and Schaechter, M. (1990). Physiology of the Bacte-
rial Cell: A Molecular Approach. Sunderland, MA: Sinauer Associates.
Nelson, K. E., Weinel, C., Paulsen, I. T., Dodson, R. J., Hilbert, H., Martins dos San-
tos, V. A. P., et al. (2002). Complete genome sequence and comparative analysis
Frontiers in Bioengineering and Biotechnology | Synthetic Biology October 2014 | Volume 2 | Article 46 | 12
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Martínez-García et al. Tools for metabolic engineering of cell factories
of the metabolically versatile Pseudomonas putida KT2440. Environ. Microbiol.
4, 799–808. doi:10.1046/j.1462-2920.2002.00366.x
Nikel, P. I., de Almeida, A., Pettinari, M. J., and Méndez, B. S. (2008a). The legacy
of HfrH: mutations in the two-component system CreBC are responsible for
the unusual phenotype of an Escherichia coli arcA mutant. J. Bacteriol. 190,
3404–3407. doi:10.1128/JB.00040-08
Nikel, P. I., Pettinari, M. J., Galvagno, M. A., and Méndez, B. S. (2008b). Poly(3-
hydroxybutyrate) synthesis from glycerol by a recombinant Escherichia coli
arcA mutant in fed-batch microaerobic cultures. Appl. Microbiol. Biotechnol. 77,
1337–1343. doi:10.1007/s00253-007-1255-7
Nikel, P. I., and de Lorenzo, V. (2013a). Implantation of unmarked regulatory and
metabolic modules in Gram-negative bacteria with specialised mini-transposon
delivery vectors. J. Biotechnol. 163, 143–154. doi:10.1016/j.jbiotec.2012.05.002
Nikel,P. I., and de Lorenzo,V. (2013b). Engineering an anaerobic metabolic regime in
Pseudomonas putida KT2440 for the anoxic biodegradation of 1,3-dichloroprop-
1-ene. Metab. Eng. 15, 98–112. doi:10.1016/j.ymben.2012.09.006
Nikel, P. I., Giordano, A. M., de Almeida, A., Godoy, M. S., and Pettinari, M. J.
(2010a). Elimination of d-lactate synthesis increases poly(3-hydroxybutyrate)
and ethanol synthesis from glycerol and affects cofactor distribution in recombi-
nant Escherichia coli. Appl. Environ. Microbiol. 76, 7400–7406. doi:10.1128/AEM.
02067-10
Nikel, P. I., Pettinari, M. J., Galvagno, M. A., and Méndez, B. S. (2010b). Metabolic
selective pressure stabilizes plasmids carrying biosynthetic genes for reduced
biochemicals in Escherichia coli redox mutants. Appl. Microbiol. Biotechnol. 88,
563–573. doi:10.1007/s00253-010-2774-1
Nikel, P. I., Martínez-García, E., and de Lorenzo, V. (2014a). Biotechnological
domestication of pseudomonads using synthetic biology. Nat. Rev. Microbiol.
12, 368–379. doi:10.1038/nrmicro3253
Nikel, P. I., Kim, J., and de Lorenzo, V. (2014b). Metabolic and regulatory rearrange-
ments underlying glycerol metabolism in Pseudomonas putida KT2440. Environ.
Microbiol. 16, 239–254. doi:10.1111/1462-2920.12224
Palmer, M. A. J., Differding, E., Gamboni, R., Williams, S. F., Peoples, O. P., Walsh,
C. T., et al. (1991). Biosynthetic thiolase from Zoogloea ramigera. Evidence for
a mechanism involving Cys-378 as the active site base. J. Biol. Chem. 266,
8369–8375.
Peoples, O. P., and Sinskey, A. J. (1989). Poly-β-hydroxybutyrate (PHB) biosynthe-
sis in Alcaligenes eutrophus H16. Identification and characterization of the PHB
polymerase gene (phbC). J. Biol. Chem. 264, 15298–15303.
Phadnis, S. H., Sasakawa, C., and Berg, D. E. (1986). Localization of action of the
IS50-encoded transposase protein. Genetics 112, 421–427.
Pratt, L. A., and Kolter, R. (1998). Genetic analysis of Escherichia coli biofilm for-
mation: roles of flagella, motility, chemotaxis and type I pili. Mol. Microbiol. 30,
285–293. doi:10.1046/j.1365-2958.1998.01061.x
Reznikoff, W. S. (2006). Tn5 transposition: a molecular tool for studying protein
structure-function. Biochem. Soc. Trans. 34, 320–323. doi:10.1042/BST20060320
Reznikoff, W. S. (2008). Transposon Tn5. Annu. Rev. Genet. 42, 269–286. doi:10.
1146/annurev.genet.42.110807.091656
Ruiz, J. A., de Almeida, A., Godoy, M. S., Mezzina, M. P., Bidart, G. N., Méndez, B.
S., et al. (2013). Escherichia coli redox mutants as microbial cell factories for the
synthesis of reduced biochemicals. Comput. Struct. Biotechnol. J. 3, e201210019.
doi:10.5936/csbj.201210019
Sambrook, J., Maniatis, T., and Fritsch, E. F. (1989). Molecular Cloning: A Laboratory
Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
Silva-Rocha, R., Martínez-García, E., Calles, B., Chavarría, M.,Arce-Rodríguez,A., de
Las Heras, A., et al. (2013). The Standard European Vector Architecture (SEVA):
a coherent platform for the analysis and deployment of complex prokaryotic
phenotypes. Nucleic Acids Res. 41, D666–D675. doi:10.1093/nar/gks1119
Simcox, T. G., Fabian, L., Kretz, K., Hedden, V., and Simcox, M. E. (1995). SanDI,
a new type-II restriction endonuclease that recognizes 5′-GG/GWCCC-3′. Gene
155, 129–130. doi:10.1016/0378-1119(94)00711-Z
Slater, S., Houmiel, K. L., Tran, M., Mitsky, T. A., Taylor, N. B., Padgette, S. R., et al.
(1998). Multiple β-ketothiolases mediate poly(β-hydroxyalkanoate) copolymer
synthesis in Ralstonia eutropha. J. Bacteriol. 180, 1979–1987.
Spiekermann, P., Rehm, B. H., Kalscheuer, R., Baumeister, D., and Steinbüchel,
A. (1999). A sensitive, viable-colony staining method using Nile red for direct
screening of bacteria that accumulate polyhydroxyalkanoic acids and other lipid
storage compounds. Arch. Microbiol. 171, 73–80. doi:10.1007/s002030050681
Steinbüchel, A., and Hein, S. (2001). Biochemical and molecular basis of micro-
bial synthesis of polyhydroxyalkanoates in microorganisms. Adv. Biochem. Eng.
Biotechnol. 71, 81–123. doi:10.1007/3-540-40021-4_3
Tyo, K. E., Zhou, H., and Stephanopoulos, G. N. (2006). High-throughput screen for
poly-3-hydroxybutyrate in Escherichia coli and Synechocystis sp. strain PCC6803.
Appl. Environ. Microbiol. 72, 3412–3417. doi:10.1128/AEM.72.5.3412-3417.2006
Verlinden, R. A., Hill, D. J., Kenward, M. A., Williams, C. D., and Radecka, I. (2007).
Bacterial synthesis of biodegradable polyhydroxyalkanoates. J. Appl. Microbiol.
102, 1437–1449. doi:10.1111/j.1365-2672.2007.03335.x
Wang, F., and Lee, S. Y. (1997). Production of poly(3-hydroxybutyrate) by fed-batch
culture of filamentation-suppressed recombinant Escherichia coli. Appl. Environ.
Microbiol. 63, 4765–4769.
Wang, Y., Yin, J., and Chen, G. Q. (2014). Polyhydroxyalkanoates, challenges and
opportunities. Curr. Opin. Biotechnol. 30, 59–65. doi:10.1016/j.copbio.2014.06.
001
Winsor, G. L., Lam, D. K. W., Fleming, L., Lo, R., Whiteside, M. D., Yu, N. Y., et al.
(2011). Pseudomonas genome database: improved comparative analysis and pop-
ulation genomics capability for Pseudomonas genomes. Nucleic Acids Res. 39,
D596–D600. doi:10.1093/nar/gkq869
Wolfe, A. J. (2005). The acetate switch. Microbiol. Mol. Biol. Rev. 69, 12–50.
doi:10.1128/MMBR.69.1.12-50.2005
Yarnell, W. S., and Roberts, J. W. (1999). Mechanism of intrinsic transcription ter-
mination and antitermination. Science 284, 611–615. doi:10.1126/science.284.
5414.611
Zhou, M., Bhasin, A., and Reznikoff, W. S. (1998). Molecular genetic analysis of
transposase-end DNA sequence recognition: cooperativity of three adjacent
base-pairs in specific interaction with a mutant Tn5 transposase. J. Mol. Biol.
276, 913–925. doi:10.1006/jmbi.1997.1579
Conflict of Interest Statement: The authors declare that the research was conducted
in the absence of any commercial or financial relationships that could be construed
as a potential conflict of interest.
Received: 22 August 2014; accepted: 13 October 2014; published online: 28 October
2014.
Citation: Martínez-García E, Aparicio T, de Lorenzo V and Nikel PI (2014) New trans-
poson tools tailored for metabolic engineering of Gram-negative microbial cell factories.
Front. Bioeng. Biotechnol. 2:46. doi: 10.3389/fbioe.2014.00046
This article was submitted to Synthetic Biology, a section of the journal Frontiers in
Bioengineering and Biotechnology.
Copyright © 2014 Martínez-García, Aparicio, de Lorenzo and Nikel. This is an open-
access article distributed under the terms of the Creative Commons Attribution License
(CC BY). The use, distribution or reproduction in other forums is permitted, provided
the original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
www.frontiersin.org October 2014 | Volume 2 | Article 46 | 13
